PEGylated Proteins Market by Product, Protein Type, Indication, End-User - Global Forecast 2025-2030- Product Image

Sale

PEGylated Proteins Market by Product, Protein Type, Indication, End-User - Global Forecast 2025-2030

Report
196 Pages
October 2024
Region: Global
360iResearch™
ID: 5888972

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The PEGylated Proteins Market grew from USD 1.43 billion in 2023 to USD 1.57 billion in 2024. It is expected to continue growing at a CAGR of 10.14%, reaching USD 2.81 billion by 2030.

PEGylated proteins, a significant innovation in the biopharmaceutical field, involve the conjugation of polyethylene glycol (PEG) to proteins to enhance their therapeutic efficacy and stability. The necessity of PEGylated proteins arises from their ability to improve pharmacokinetics, reduce immunogenicity, and prolong circulation time in the bloodstream, making them essential in treating chronic diseases like cancer, hepatitis, and rheumatoid arthritis. Application domains span from drug delivery systems to the development of next-generation biologics, while end-use extends across pharmaceutical companies, biotechnology firms, and research institutions.

Market insights reveal that the rise in chronic disease prevalence, advancing biotechnology, and the need for targeted drug delivery systems are pivotal growth factors. The biopharmaceutical industry's increasing investment in R&D and the expanding use of biologics further propel market expansion. However, the complexity of the PEGylation process, high production costs, and regulatory hurdles pose limitations and challenges to market growth.

Emerging opportunities lie in the innovation of site-specific PEGylation and the development of novel PEG derivatives, offering improved safety and efficacy profiles. Recommendations for capturing these opportunities include investing in cutting-edge research to enhance conjugation techniques and streamline production processes, thereby reducing costs and improving scalability. Collaboration with academic institutions and other biopharmaceutical companies can also foster innovation and speed up market entry.

Furthermore, geographical expansion into emerging markets with a burgeoning pharmaceutical infrastructure offers untapped potential. Despite the promising outlook, entry barriers such as stringent regulatory frameworks and patent expiry of certain PEGylated drugs require strategic planning. The market for PEGylated proteins remains dynamic with a focus on innovation-driven growth, emphasizing tailored solutions to meet specific therapeutic needs while navigating the complex regulatory landscape efficiently. By capitalizing on technological advancements and diversifying applications, businesses can achieve a competitive edge in this evolving market landscape.

Understanding Market Dynamics in the PEGylated Proteins Market

The PEGylated Proteins Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of chronic diseases among population
- Growing investments in pharmaceutical research and development programs
- Modernization of healthcare infrastructure across economies
Market Restraints
- High costs associated with PEGylation process
Market Opportunities
- Higher emphasis on biotechnology and biomolecular engineering
- Potential of PEGylation in target specific drug delivery
Market Challenges
- Time consuming stringent drug approval processes

Exploring Porter’s Five Forces for the PEGylated Proteins Market

Porter’s Five Forces framework further strengthens the insights of the PEGylated Proteins Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the PEGylated Proteins Market

External macro-environmental factors deeply influence the performance of the PEGylated Proteins Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the PEGylated Proteins Market

The PEGylated Proteins Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the PEGylated Proteins Market

The PEGylated Proteins Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the PEGylated Proteins Market

The PEGylated Proteins Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the PEGylated Proteins Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Aurigene Pharmaceutical Services Limited, Biogen Inc., BioMarin, Biomatrik Inc., Celares GmbH, Creative PEGWorks, Enzon Pharmaceuticals, Inc., Exelead, F. Hoffmann-La Roche Ltd., Horizon Therapeutics PLC, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio, Inc., Ligand Pharmaceuticals Inc, Merck KGaA, NOF CORPORATION, Novo Nordisk A/S, Pfizer Inc., Profacgen, Quanta BioDesign Ltd, QuiaPEG Pharmaceuticals Holding AB, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., and UCB S.A..

Market Segmentation & Coverage

This research report categorizes the PEGylated Proteins Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- PEGylation Kits
- PEGylation Reagents
  - Biofunctional PEGs
  - Branched PEGs
  - Monofunctional Linear PEGs
  - Multi-Arm PEGs
- Services
Protein Type
- Colony-Stimulating Factor
- Erythropoietin
- Interferons
- mAbs
- Recombinant Factor VII
Indication
- Autoimmune Diseases
- Cancer
- Gastrointestinal Disorders
- Hemophilia
- Hepatitis
- Multiple Sclerosis
End-User
- Academic & Research Institutes
- CROs
- Pharmaceutical & Biopharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases among population
5.1.1.2. Growing investments in pharmaceutical research and development programs
5.1.1.3. Modernization of healthcare infrastructure across economies
5.1.2. Restraints
5.1.2.1. High costs associated with PEGylation process
5.1.3. Opportunities
5.1.3.1. Higher emphasis on biotechnology and biomolecular engineering
5.1.3.2. Potential of PEGylation in target specific drug delivery
5.1.4. Challenges
5.1.4.1. Time consuming stringent drug approval processes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. PEGylated Proteins Market, by Product

6.1. Introduction
6.2. PEGylation Kits
6.3. PEGylation Reagents
6.3.1. Biofunctional PEGs
6.3.2. Branched PEGs
6.3.3. Monofunctional Linear PEGs
6.3.4. Multi-Arm PEGs
6.4. Services

7. PEGylated Proteins Market, by Protein Type

7.1. Introduction
7.2. Colony-Stimulating Factor
7.3. Erythropoietin
7.4. Interferons
7.5. mAbs
7.6. Recombinant Factor VII

8. PEGylated Proteins Market, by Indication

8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Gastrointestinal Disorders
8.5. Hemophilia
8.6. Hepatitis
8.7. Multiple Sclerosis

9. PEGylated Proteins Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. CROs
9.4. Pharmaceutical & Biopharmaceutical Companies

10. Americas PEGylated Proteins Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific PEGylated Proteins Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa PEGylated Proteins Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. PEGYLATED PROTEINS MARKET RESEARCH PROCESS
FIGURE 2. PEGYLATED PROTEINS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PEGYLATED PROTEINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PEGYLATED PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PEGYLATED PROTEINS MARKET DYNAMICS
TABLE 7. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY BIOFUNCTIONAL PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY BRANCHED PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY MONOFUNCTIONAL LINEAR PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY MULTI-ARM PEGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY COLONY-STIMULATING FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY MABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY RECOMBINANT FACTOR VII, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PEGYLATED PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 51. CANADA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PEGYLATED PROTEINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 78. CHINA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. CHINA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 83. INDIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 84. INDIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. INDIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 94. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. JAPAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 123. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 124. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. THAILAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA PEGYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 139. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 140. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. DENMARK PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 145. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. EGYPT PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 155. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. FRANCE PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 160. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. GERMANY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 169. ITALY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 170. ITALY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. ITALY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. NORWAY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 189. POLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 190. POLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. POLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 194. QATAR PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 195. QATAR PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. QATAR PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 214. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 230. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PEGYLATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY PROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PEGYLATED PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. PEGYLATED PROTEINS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 243. PEGYLATED PROTEINS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the PEGylated Proteins Market, which are profiled in this report, include:

Abcam PLC
Aurigene Pharmaceutical Services Limited
Biogen Inc.
BioMarin
Biomatrik Inc.
Celares GmbH
Creative PEGWorks
Enzon Pharmaceuticals, Inc.
Exelead
F. Hoffmann-La Roche Ltd.
Horizon Therapeutics PLC
Iris Biotech GmbH
JenKem Technology USA Inc.
Laysan Bio, Inc.
Ligand Pharmaceuticals Inc
Merck KGaA
NOF CORPORATION
Novo Nordisk A/S
Pfizer Inc.
Profacgen
Quanta BioDesign Ltd
QuiaPEG Pharmaceuticals Holding AB
Takeda Pharmaceuticals Company Limited
Thermo Fisher Scientific Inc.
UCB S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.57 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.81 Billion
Compound Annual Growth Rate	10.1%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the PEGylated Proteins Market

Exploring Porter’s Five Forces for the PEGylated Proteins Market

Applying PESTLE Analysis to the PEGylated Proteins Market

Analyzing Market Share in the PEGylated Proteins Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the PEGylated Proteins Market

Strategic Recommendations for Success in the PEGylated Proteins Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

PEGylated Proteins Global Market Report 2024

PEGylated Proteins Market

PEGylated Proteins Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

PEGylated Proteins Market Report by Product, Protein Type, Application, End User, and Region 2024-2032

PEGylated Proteins - Global Strategic Business Report